The ROC curve analysis supported these results, demonstrating the moderate predictive power of Humanin for identifying patients with endothelial dysfunction, indicating its potential as a biomarker for both endothelial health and overall prognosis in RA patients. This evidence concerns the gene MT-RNR2 and rheumatoid arthritis.